SPYRAL DYSTAL Renal Denervation Global Clinical Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 128 participants.
Also called NCT04311086
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 128 participants
- Sponsor
- Registry
-
NCT04311086
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Germany, Greece, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT04311086. Allocation not applicable; no masking; primary purpose treatment. Start 2020-06-12 (actual); primary completion 2022-12-22 (actual). Results posted on 2024-04-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SPYRAL DYSTAL Renal Denervation Global Clinical Study
- Condition
- Hypertension
- Condition
- Vascular Diseases
- Condition
- Cardiovascular Diseases
- Intervention (Device)
- Renal Denervation (Symplicity Spyral™)
- Lead sponsor
- Medtronic Vascular
Record details
- Record id
cardio:ct-nct04311086- Content hash
fc6a9820d67a3e0da8e926dff316bd6250000f2148f87ec55bfe6c4930edfd87